ChitogenX Inc.
ChitogenX Inc., an orthopaedic and sports medicine biologics company, engages in the research and development of novel therapeutic soft tissue repair technologies to enhance the success rate of orthopaedic and sports medicine surgeries in Canada. It develops Ortho-R, a biopolymer for rotator cuff repair; and Ortho-M, a biopolymer for meniscus repair. The company was formerly known as Ortho Regene… Read more
ChitogenX Inc. (CHNXF) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of October 2024: -0.005x
Based on the latest financial reports, ChitogenX Inc. (CHNXF) has a cash flow conversion efficiency ratio of -0.005x as of October 2024.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($36.00K) by net assets ($-7.36 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
ChitogenX Inc. - Cash Flow Conversion Efficiency Trend (2019–2024)
This chart illustrates how ChitogenX Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
ChitogenX Inc. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of ChitogenX Inc. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
ODFJELL DRILL
MU:OD3
|
N/A |
|
Stark Focus Group Inc
PINK:SKFG
|
0.056x |
|
Strats Trust US Cellular GIC
NYSE:GJH
|
N/A |
|
Alussa Energy Acquisition Corp. II
NYSE:ALUB-UN
|
N/A |
|
Karbon Capital Partners Corp. Class A Ordinary Shares
NASDAQ:KBON
|
N/A |
|
United Corporations Limited
TO:UNC
|
-0.001x |
|
VNET Group Inc
STU:217A
|
0.062x |
|
Vivanco Gruppe AG
F:VG0K
|
0.164x |
Annual Cash Flow Conversion Efficiency for ChitogenX Inc. (2019–2024)
The table below shows the annual cash flow conversion efficiency of ChitogenX Inc. from 2019 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-01-31 | $-6.18 Million | $-1.01 Million | 0.163x | -49.72% |
| 2023-01-31 | $-9.84 Million | $-3.20 Million | 0.325x | -28.34% |
| 2022-01-31 | $-7.10 Million | $-3.22 Million | 0.453x | -72.62% |
| 2021-01-31 | $-1.80 Million | $-2.98 Million | 1.655x | +149.58% |
| 2020-01-31 | $-2.40 Million | $-1.59 Million | 0.663x | -71.81% |
| 2019-01-31 | $-589.07K | $-1.39 Million | 2.353x | -- |